Arcadia Biosciences (RKDA) Operating Margin (2016 - 2025)
Arcadia Biosciences (RKDA) has disclosed Operating Margin for 12 consecutive years, with 88.63% as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Operating Margin rose 2588.0% year-over-year to 88.63%, compared with a TTM value of 65.82% through Sep 2025, down 4949.0%, and an annual FY2024 reading of 72.31%, up 6469.0% over the prior year.
- Operating Margin was 88.63% for Q3 2025 at Arcadia Biosciences, down from 34.43% in the prior quarter.
- Across five years, Operating Margin topped out at 987.87% in Q3 2022 and bottomed at 643.24% in Q1 2021.
- Average Operating Margin over 5 years is 98.15%, with a median of 114.51% recorded in 2024.
- The sharpest move saw Operating Margin skyrocketed 313865bps in 2021, then plummeted -109550bps in 2023.
- Year by year, Operating Margin stood at 373.6% in 2021, then skyrocketed by 105bps to 17.58% in 2022, then soared by 351bps to 79.28% in 2023, then tumbled by -337bps to 187.57% in 2024, then surged by 53bps to 88.63% in 2025.
- Business Quant data shows Operating Margin for RKDA at 88.63% in Q3 2025, 34.43% in Q2 2025, and 44.17% in Q1 2025.